Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1974 Apr 6;2(5909):14–16. doi: 10.1136/bmj.2.5909.14

Response to Propranolol and Diazepam in Somatic and Psychic Anxiety

P J Tyrer, M H Lader
PMCID: PMC1610184  PMID: 4595181

Abstract

A total of 12 chronically anxious psychiatric outpatients were treated with racemic propranolol (Inderal), diazepam (Valium), and placebo for one week each, using a balanced cross-over experimental design. Six patients had predominantly somatic anxiety, complaining mostly of bodily symptoms, and six had mainly psychic anxiety, complaining primarily of psychological symptoms. Clinical ratings of anxiety were made by patient and psychiatrist after each treatment. Though diazepam was in general more effective than propranolol or placebo in relieving anxiety, propranolol was more effective than placebo in patients with somatic anxiety but not in those with psychic anxiety. We suggest that propranolol should be reserved for patients whose anxiety symptoms are mainly somatic.

Full text

PDF
14

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonn J. A., Turner P., Hicks D. C. Beta-adrenergic-receptor blockade with practolol in treatment of anxiety. Lancet. 1972 Apr 15;1(7755):814–815. doi: 10.1016/s0140-6736(72)90799-4. [DOI] [PubMed] [Google Scholar]
  2. Conway M. Final examinations. Practitioner. 1971 Jun;206(236):795–800. [PubMed] [Google Scholar]
  3. Frohlich E. D., Dustan H. P., Page I. H. Hyperdynamic beta-adrenergic circulatory state. Arch Intern Med. 1966 May;117(5):614–619. [PubMed] [Google Scholar]
  4. Granville-Grossman K. L., Turner P. The effect of propranolol on anxiety. Lancet. 1966 Apr 9;1(7441):788–790. doi: 10.1016/s0140-6736(66)91863-0. [DOI] [PubMed] [Google Scholar]
  5. HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55. doi: 10.1111/j.2044-8341.1959.tb00467.x. [DOI] [PubMed] [Google Scholar]
  6. HOLMGREN A., JONSSON B., LEVANDER M., LINDERHOLM H., MOSSFELDT F., SJOSTRAND T., STROM G. Physical training of patients with vasoregulatory asthenia. Acta Med Scand. 1957 Oct 15;158(6):437–446. doi: 10.1111/j.0954-6820.1957.tb15510.x. [DOI] [PubMed] [Google Scholar]
  7. Lader M. H., Tyrer P. J. Central and peripheral effects of propranolol and sotalol in normal human subjects. Br J Pharmacol. 1972 Jul;45(3):557–560. doi: 10.1111/j.1476-5381.1972.tb08113.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Marsden C. D., Gimlette T. M., McAllister R. G., Owen D. A., Miller T. N. Effect of beta-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients. Acta Endocrinol (Copenh) 1968 Mar;57(3):353–362. doi: 10.1530/acta.0.0570353. [DOI] [PubMed] [Google Scholar]
  9. McMillin W. P. Oxprenolol in anxiety. Lancet. 1973 May 26;1(7813):1193–1193. doi: 10.1016/s0140-6736(73)91202-6. [DOI] [PubMed] [Google Scholar]
  10. Nordenfelt I., Persson S., Redfors A. Effect of a new adrenergic beta-blocking agent, H 56-28, on nervous heart complaints. Acta Med Scand. 1968 Dec;184(6):465–471. [PubMed] [Google Scholar]
  11. ROBERTS J. M., HAMILTON M. Treatment of anxiety states. I. The effects of suggestion on the symptoms of anxiety states. J Ment Sci. 1958 Oct;104(437):1052–1055. doi: 10.1192/bjp.104.437.1052. [DOI] [PubMed] [Google Scholar]
  12. Ramsay I., Greer S., Bagley C. Propranolol in neurotic and thyrotoxic anxiety. Br J Psychiatry. 1973 May;122(570):555–560. doi: 10.1192/bjp.122.5.555. [DOI] [PubMed] [Google Scholar]
  13. Shand D. G., Nuckolls E. M., Oates J. A. Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112–120. doi: 10.1002/cpt1970111112. [DOI] [PubMed] [Google Scholar]
  14. Thadani U., Sharma B., Meeran M. K., Majid P. A., Whitaker W., Taylor S. H. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20;1(5846):138–142. doi: 10.1136/bmj.1.5846.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Turner P., Granville-Grossman K. L. Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state. Lancet. 1965 Dec 25;2(7426):1316–1318. doi: 10.1016/s0140-6736(65)92340-8. [DOI] [PubMed] [Google Scholar]
  16. Tyrer P. J., Lader M. H. Effects of beta adrenergic blockade with sotalol in chronic anxiety. Clin Pharmacol Ther. 1973 May-Jun;14(3):418–426. doi: 10.1002/cpt1973143418. [DOI] [PubMed] [Google Scholar]
  17. Tyrer P. J. Relevance of bodily feelings in emotion. Lancet. 1973 Apr 28;1(7809):915–916. doi: 10.1016/s0140-6736(73)91365-2. [DOI] [PubMed] [Google Scholar]
  18. Wheatley D. Comparative effects of propranolol and chlordiazepoxide in anxiety states. Br J Psychiatry. 1969 Dec;115(529):1411–1412. doi: 10.1192/bjp.115.529.1411. [DOI] [PubMed] [Google Scholar]
  19. van der Kleijn E. Pharmacokinetics of distribution and metabolism of ataractic drugs and an evaluation of the site of antianxiety activity. Ann N Y Acad Sci. 1971 Jul 6;179:115–125. doi: 10.1111/j.1749-6632.1971.tb46894.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES